Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran in Fibromyalgia
NCT00098124Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia (FM), sponsored by Forest Laboratories. Started Nov 2004; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00098124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098124.